Antibiotic therapy as a risk factor for chronic residual and phantom limb pain after combat-related amputation: a 212-patient cohort study

Read full text Summarise with VIRAT
Authors: Kateryna Ksenchyna, Oleh Ksenchyn, Oleksandr Nazarchuk, Д. В. Дмитрієв
Cited by: 0
References: 23

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background: Antibiotic (AB) therapy is standard in managing combat-related infections, particularly after traumatic limb amputations. However, prolonged or combined antibiotic regimens may contribute to neuroinflammatory processes that predispose patients to chronic post-amputation pain (ChPAP), which combines the consepts of chronic residual limb pain (RLP) and phantom limb pain (PLP). Objective: To investigate associations between antibiotic use (duration, type, and combination) and the development of RLP and PLP in post-amputation military patients. Methods: This retrospective cohort study evaluated 212 military personnel treated between 2022 and 2024 for traumatic amputations. Antibiotic regimens, pain intensity, type, and chronicity were analyzed. Results: Chronic RLP/PLP developed in 94 patients (44.3%). Prolonged antibiotic use (>21 days) and combined regimens (≥2 antibiotics) were) were related with increased ChPAP risk in limbs Neuropathic pain was predominant in patients exposed to fluoroquinolones or metronidazole. Conclusion: Extended and multi-agent antibiotic therapy was associated with ChPAP after combat-related limb amputation. Personalized antimicrobial stewardship and early pain screening are recommended in this high-risk population.

Fields of Study & Subjects

Pain Management and Treatment Anesthesia and Pain Management Pain Mechanisms and Treatments

Publication details

Journal / source
Frontiers in Pain Research
Volume
7
Pages
1715446–1715446
Publication date
18 March 2026
Language
EN